MRGBP inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of MRGBP, a protein known as MRG-binding protein. MRGBP functions as a critical component of the chromatin-modifying complex, which plays a key role in the regulation of gene expression. MRGBP interacts with other proteins, such as the MRG family (MORF-related gene-binding proteins), to regulate chromatin structure and facilitate the acetylation and deacetylation of histones. These modifications are essential for controlling the accessibility of transcriptional machinery to specific regions of DNA, influencing which genes are turned on or off in response to cellular signals. By inhibiting MRGBP, researchers can disrupt the regulation of chromatin dynamics, providing a tool to study its role in transcriptional control, chromatin remodeling, and broader aspects of gene expression regulation.
In research, MRGBP inhibitors are valuable for exploring the molecular mechanisms by which chromatin structure influences gene expression and how MRGBP contributes to the organization of chromatin-modifying complexes. By blocking MRGBP activity, scientists can investigate how its inhibition affects the acetylation patterns of histones and the accessibility of certain gene regions, particularly focusing on how these disruptions alter transcriptional activity and cellular differentiation. This inhibition allows researchers to study downstream effects on processes such as cellular growth, response to environmental stimuli, and epigenetic regulation, where chromatin modification plays a pivotal role. Additionally, MRGBP inhibitors provide insights into the interactions between MRGBP and other proteins within chromatin-remodeling complexes, shedding light on the complex regulatory networks that govern gene expression. Through these studies, the use of MRGBP inhibitors enhances our understanding of chromatin biology, epigenetic regulation, and the broader implications of chromatin structure in maintaining cellular function and identity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can alter chromatin structure and potentially influence MRGBP-related gene regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
An inhibitor of DNA methyltransferases, affecting DNA methylation and possibly impacting MRGBP's role in chromatin modification. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, altering chromatin structure and potentially influencing MRGBP function. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
A universal methyl donor, involved in various methylation reactions including chromatin modification, possibly affecting MRGBP activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor that could indirectly influence MRGBP by altering methylation patterns in chromatin. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective histone deacetylase inhibitor, potentially impacting MRGBP function by altering chromatin accessibility. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A histone deacetylase inhibitor used in cancer therapy, which could indirectly affect MRGBP function in gene regulation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor with potential indirect effects on chromatin structure and MRGBP's role in gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
An inhibitor of DNA methyltransferases, affecting chromatin modification and potentially impacting MRGBP activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor that could indirectly affect MRGBP's role in chromatin remodeling and gene regulation. | ||||||